Frontier Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.1M | Sell |
535,763
-233,538
| -30% | -$10.1M | 0.21% | 170 |
|
|
2025
Q1 | $26.6M | Sell |
769,301
-306,557
| -28% | -$10.6M | 0.29% | 133 |
|
|
2024
Q4 | $29.5M | Buy |
1,075,858
+572,696
| +114% | +$15.7M | 0.28% | 138 |
|
|
2024
Q3 | $12.8M | Buy |
503,162
+354,794
| +239% | +$9.03M | 0.12% | 202 |
|
|
2024
Q2 | $3.76M | Sell |
148,368
-301,168
| -67% | -$7.63M | 0.04% | 259 |
|
|
2024
Q1 | $13.9M | Buy |
+449,536
| New | +$13.9M | 0.13% | 196 |
|